In today’s fast-paced clinical research landscape, time is money—literally. The ability to streamline processes, reduce time spent on manual tasks, and cut costs is crucial for success. At Clinials, we understand this, and that’s why our platform is designed to create tangible Return on Investment (ROI) for our customers, particularly Contract Research Organizations (CROs) and… Continue reading Maximizing ROI with Clinials: How Our Platform Streamlines Clinical Trial Operations
What are the top key pain points for Sites and CRO’s? Here’s a table from this comprehensive study of site engagement literature conducted by the Tufts University CSDD to identify the primary themes and “pain points” or challenges that sites contend with on a regular basis, including those captured by SCRS. How does Clinials… Continue reading Key Pain Points for CRO’s and Sites
Clinials were the first to use AI to generate a plain language synopsis (PLS) from a protocol Completed in 2022, this innovation was in response to European Union Clinical Trial Regulation 536 EU which mandated that a a summary be “written in a manner that is understandable to laypersons”. And now we have another first.… Continue reading What is a Plain Language Protocol Synopsis (PLPS)
In the rapidly evolving field of artificial intelligence, the integration of AI into healthcare demands not just innovation but a rigorous commitment to safety. As these technologies play an increasingly pivotal role in patient care, diagnosis, and treatment, the importance of ensuring their reliability and trustworthiness cannot be overstated. The potential of AI to revolutionize… Continue reading How Clinials is Building Safety into its AI Platform
When patients feel heard and valued, trust flourishes, leading to increased patient recruitment In the realm of clinical trials, trust is not just a desirable quality—it’s the linchpin that holds the entire process together. From the intricate dance between biotechnology sponsors, CROs (Contract Research Organizations), and research sites, to the pivotal relationships between patients and… Continue reading When trust flourishes leading to increased patient recruitment
How can Biotechnology and Medtech device companies use AI to increase Diversity in their clinical trials? Global pharmaceutical companies will need to make use of AI’s transformative potential in addressing the diversity gap in clinical trials to illuminate a pathway towards more inclusive, accessible and patient-centric healthcare practices. Innovative biotechnology and Medtech device companies are… Continue reading Pharma to use AI to increase Diversity in their clinical trials
US:
867 Boylston Street
5th Floor
Boston, MA 02116
